Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur J Moss

Circulation

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Circulation|October 9, 2014
New insights into the arrhythmogenic substrate of the long QT syndromeArthur J Moss
Circulation|April 17, 2008
Life versus deathArthur J Moss
Circulation|February 8, 2013
Narrow QRS is not the right substrate for cardiac resynchronization therapyArthur J Moss
Circulation|May 19, 2005
Should everyone with an ejection fraction less than or equal to 30% receive an implantable cardioverter-defibrillator? Everyone with an ejection fraction < or = 30% should receive an implantable cardioverter-defibrillatorArthur J Moss
Circulation|March 9, 2005
25th anniversary of the International Long-QT Syndrome Registry: an ongoing quest to uncover the secrets of long-QT syndromeArthur J Moss, Peter J Schwartz
Circulation|July 24, 2002
Images in cardiovascular medicine. Ventricular fibrillation during swimming in a patient with long-QT syndromePeter Ott, Frank I Marcus, Arthur J Moss
Circulation|August 29, 2015
Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry)Valentina Kutyifa, Arthur J Moss, Helmut Klein, et al.
Circulation|June 14, 2006
Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the multicenter automatic defibrillator implantation trial IIIlan Goldenberg, Arthur J Moss, W Jackson Hall, et al.
Circulation|November 8, 2006
Genotype-specific onset of arrhythmias in congenital long-QT syndrome: possible therapy implicationsHanno L Tan, Abdennasser Bardai, Wataru Shimizu, et al.
Circulation|September 15, 2010
Long-term benefit of primary prevention with an implantable cardioverter-defibrillator: an extended 8-year follow-up study of the Multicenter Automatic Defibrillator Implantation Trial IIIlan Goldenberg, John Gillespie, Arthur J Moss, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Circulation|October 9, 2014
New insights into the arrhythmogenic substrate of the long QT syndromeArthur J Moss
Circulation|April 17, 2008
Life versus deathArthur J Moss
Circulation|February 8, 2013
Narrow QRS is not the right substrate for cardiac resynchronization therapyArthur J Moss
Circulation|May 19, 2005
Should everyone with an ejection fraction less than or equal to 30% receive an implantable cardioverter-defibrillator? Everyone with an ejection fraction < or = 30% should receive an implantable cardioverter-defibrillatorArthur J Moss
Circulation|March 9, 2005
25th anniversary of the International Long-QT Syndrome Registry: an ongoing quest to uncover the secrets of long-QT syndromeArthur J Moss, Peter J Schwartz
Circulation|July 24, 2002
Images in cardiovascular medicine. Ventricular fibrillation during swimming in a patient with long-QT syndromePeter Ott, Frank I Marcus, Arthur J Moss
Circulation|August 29, 2015
Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry)Valentina Kutyifa, Arthur J Moss, Helmut Klein, et al.
Circulation|June 14, 2006
Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the multicenter automatic defibrillator implantation trial IIIlan Goldenberg, Arthur J Moss, W Jackson Hall, et al.
Circulation|November 8, 2006
Genotype-specific onset of arrhythmias in congenital long-QT syndrome: possible therapy implicationsHanno L Tan, Abdennasser Bardai, Wataru Shimizu, et al.
Circulation|September 15, 2010
Long-term benefit of primary prevention with an implantable cardioverter-defibrillator: an extended 8-year follow-up study of the Multicenter Automatic Defibrillator Implantation Trial IIIlan Goldenberg, John Gillespie, Arthur J Moss, et al.
Pageof 4